<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A preliminary analysis of the effect of long-term therapy with oral papaverine has been made in 11 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> due to cerebral <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The cases were classified as remote <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> (6 patients) or <z:e sem="disease" ids="C0042568" disease_type="Disease or Syndrome" abbrv="">vertebrobasilar arterial insufficiency</z:e> (5 patients) </plain></SENT>
<SENT sid="2" pm="."><plain>The patients received 225 mg or 450 mg daily, assigned in a double-blind manner </plain></SENT>
<SENT sid="3" pm="."><plain>Most showed clinical improvement and improvement on the EEG </plain></SENT>
<SENT sid="4" pm="."><plain>There was a statistically significant increase in regional cerebral blood flow in the vertebrobasilar arterial distribution, including the brain stem and cerebellar and posterior cerebral regions, particularly in the right hemisphere </plain></SENT>
<SENT sid="5" pm="."><plain>Evidence appears to indicate that zones of severe remote <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> are refractory to pharmacologically induced vasodilation </plain></SENT>
</text></document>